Event

The PSI & DIA’s Journal Club: Subgroup Analyses Webinar 24th October 2019, 4pm - 5:00pm (BST)

Add to:

Join us in our discussion on Subgroup Analyses at 4pm (BST) on Thursday 24th October.

Please click here to view the flyer.

REGISTER HERE:  https://attendee.gotowebinar.com/register/1104192650747595019

Join us in our discussion on Subgroup Analyses at 4pm (BST) on Thursday 24th October.

Our two presenters are Cynthia Huber from the Department of Medical Statistics, University Medical Centre Gottingen and Christoph Muysers and Bodo Kirsch from Bayer. The chair of the webinar is Anna Berglind from AstraZeneca.

(PSI)  A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations – Cynthia Huber, Norbert Benda and Tim Friede

(DIA) A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies – Christoph Muysers et al.

The webinar is sponsored by Wiley who will make the PSI paper free to access for a few weeks before and after the webinar.

Upcoming Events

PSI ToxSIG Webinar: Beyond the looking glass - Interpreting animal welfare & behaviour by monitoring & assessing mice activity data

Analysing continuously collected locomotive activity data to interpret mice welfare and behaviour.

PSI Journal Club: Survival Analysis

Our next journal club features two papers on the topic of Survival Analysis. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.

PSI VisSIG Webinar: Rapid Insights to Data

The field of data visualization is the intersection of data journalism, statistics, graphic design, computer science, neuroscience, and cognitive psychology. We will focus on the latter two fields of data visualization as it relates to data visualization: neuroscience and cognitive psychology.

Latest Jobs

Biostatistician Project Leader

As a statistician in the Biostatistics and Programming Department, you will be responsible for the methodological and statistical aspects of projects in early clinical development in order to optimize the early development plan and ensure its coherence.

Director Biostatistics

By joining our company, in this role you will apply your skills and experience in support of developing scientifically based arguments aiming to provide fair accessibility to our company’s drugs and vaccines making a real difference in patient’s lives.

Director of Statistics

As a Director of Statistics, you will be accountable for guiding statisticians in their work, performing senior review of documentation and output deliveries, providing oversight and advising on best practices approach to statistics for clinical trials.